Literature DB >> 24338218

Hypoxia-inducible factor-1α and its role in the proliferation of retinoblastoma cells.

Bruno F Fernandes1, James Coates, Alexandre N Odashiro, Carlos Quezada, Aimee Huynh, Patricia R Odashiro, Macanori Odashiro, Miguel N Burnier.   

Abstract

In order to better understand the role of HIF-1α in the proliferation of the retinoblastoma cells, a siRNA knockdown of HIF-1α followed by a proliferation assay was performed. Further sequencing was then carried out in order to assess knockdown efficiency and expression of HIF-1α. Upregulation of HIF-1α gene expression in CoCl2-treated retinoblastoma cells was demonstrated via melting curve analysis from PCR tests and was further analyzed using western blot and densitometry analysis. Reduction of HIF-1α expression in retinoblastoma, post HIF-1α knockdown, was observed after siRNA transfection into Y-79 cells. Knockdown of HIF-1α resulted in a significant decrease in proliferation thereby demonstrating that HIF-1α is involved in promoting survival and proliferation in retinoblastoma cells. Stabilization of HIF-1α in retinoblastoma cells using CoCl2 was unsuccessful.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24338218     DOI: 10.1007/s12253-013-9728-8

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  28 in total

Review 1.  Functions of the retinoblastoma protein.

Authors:  W G Kaelin
Journal:  Bioessays       Date:  1999-11       Impact factor: 4.345

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 3.  HIF-1 and HIF-2 transcription factors--similar but not identical.

Authors:  Agnieszka Loboda; Alicja Jozkowicz; Jozef Dulak
Journal:  Mol Cells       Date:  2010-04-12       Impact factor: 5.034

4.  Expression of vascular endothelial growth factor in retinoblastoma.

Authors:  Carolina Areán; Maria E Orellana; Daniel Abourbih; Carmen Abreu; Imelda Pifano; Miguel N Burnier
Journal:  Arch Ophthalmol       Date:  2010-02

Review 5.  Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy.

Authors:  P Vaupel; D K Kelleher; M Höckel
Journal:  Semin Oncol       Date:  2001-04       Impact factor: 4.929

6.  Toll-like receptor activation and hypoxia use distinct signaling pathways to stabilize hypoxia-inducible factor 1α (HIF1A) and result in differential HIF1A-dependent gene expression.

Authors:  Jonathan Jantsch; Melanie Wiese; Johannes Schödel; Kirstin Castiglione; Joachim Gläsner; Sophie Kolbe; David Mole; Ulrike Schleicher; Kai-Uwe Eckardt; Michael Hensel; Roland Lang; Christian Bogdan; Markus Schnare; Carsten Willam
Journal:  J Leukoc Biol       Date:  2011-06-17       Impact factor: 4.962

7.  Treatment with connexin 46 siRNA suppresses the growth of human Y79 retinoblastoma cell xenografts in vivo.

Authors:  Diana B Burr; Samuel A Molina; Debarshi Banerjee; Derek M Low; Dolores J Takemoto
Journal:  Exp Eye Res       Date:  2011-02-12       Impact factor: 3.467

8.  Targeting hypoxia, a novel treatment for advanced retinoblastoma.

Authors:  Hinda Boutrid; Maria-Elena Jockovich; Timothy G Murray; Yolanda Piña; William J Feuer; Theodore J Lampidis; Colleen M Cebulla
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03-07       Impact factor: 4.799

9.  Advanced retinoblastoma treatment: targeting hypoxia by inhibition of the mammalian target of rapamycin (mTOR) in LH(BETA)T(AG) retinal tumors.

Authors:  Y Piña; C Decatur; Tg Murray; Sk Houston; D Gologorsky; M Cavalcante; L Cavalcante; E Hernandez; M Celdran; W Feuer; T Lampidis
Journal:  Clin Ophthalmol       Date:  2011-03-07

10.  Relative quantification of mRNA: comparison of methods currently used for real-time PCR data analysis.

Authors:  Stefan Cikos; Alexandra Bukovská; Juraj Koppel
Journal:  BMC Mol Biol       Date:  2007-12-20       Impact factor: 2.946

View more
  3 in total

1.  Suppression of Disheveled-Axin Domain Containing 1 (DIXDC1) by MicroRNA-186 Inhibits the Proliferation and Invasion of Retinoblastoma Cells.

Authors:  Xuanyi Che; Yuanjie Qian; Di Li
Journal:  J Mol Neurosci       Date:  2017-12-20       Impact factor: 3.444

2.  MicroRNA-320 regulates autophagy in retinoblastoma by targeting hypoxia inducible factor-1α.

Authors:  Yong Liang; Xi Chen; Zhu Liang
Journal:  Exp Ther Med       Date:  2017-07-11       Impact factor: 2.447

3.  RB1 loss triggers dependence on ESRRG in retinoblastoma.

Authors:  Matthew G Field; Jeffim N Kuznetsoff; Michelle G Zhang; James J Dollar; Michael A Durante; Yoseph Sayegh; Christina L Decatur; Stefan Kurtenbach; Daniel Pelaez; J William Harbour
Journal:  Sci Adv       Date:  2022-08-19       Impact factor: 14.957

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.